95 related articles for article (PubMed ID: 19196364)
1. Proton pump inhibitor omeprazole use is associated with low bone mineral density in maintenance haemodialysis patients.
Kirkpantur A; Altun B; Arici M; Turgan C
Int J Clin Pract; 2009 Feb; 63(2):261-8. PubMed ID: 19196364
[TBL] [Abstract][Full Text] [Related]
2. Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis.
Jamal SA; Hayden JA; Beyene J
Am J Kidney Dis; 2007 May; 49(5):674-81. PubMed ID: 17472850
[TBL] [Abstract][Full Text] [Related]
3. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
Lange U; Teichmann J; Müller-Ladner U; Strunk J
Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
[TBL] [Abstract][Full Text] [Related]
4. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study.
Malik P; Gasser RW; Kemmler G; Moncayo R; Finkenstedt G; Kurz M; Fleischhacker WW
Alcohol Clin Exp Res; 2009 Feb; 33(2):375-81. PubMed ID: 19053976
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study.
Bauer M; Fairbanks L; Berghöfer A; Hierholzer J; Bschor T; Baethge C; Rasgon N; Sasse J; Whybrow PC
J Affect Disord; 2004 Dec; 83(2-3):183-90. PubMed ID: 15555712
[TBL] [Abstract][Full Text] [Related]
6. [Vitamin D receptor gene polymorphism and the rate of bone loss of the femur neck and lumbar spine in hemodialized patients with chronic renal failure].
Karkoszka H; Chudek J; Strzelczyk P; Wiecek A; Schmidt-Gayk H; Ritz E; Kokot F
Pol Merkur Lekarski; 1998 Oct; 5(28):199-202. PubMed ID: 10101442
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density following long-term use of antiepileptic drugs in a tropical Asian country.
Phabphal K; Limapichat K; Sathirapanya P; Setthawatcharawanich S; Leelawattana R; Thammakumpee N; Thamaprasit A; Geater A
Epileptic Disord; 2008 Sep; 10(3):213-8. PubMed ID: 18782690
[TBL] [Abstract][Full Text] [Related]
9. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
Buyukkaplan US; Akkaya A; Yildiz M; Bircan A; Aksoy Dogan A; Ozturk O
J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
[TBL] [Abstract][Full Text] [Related]
10. Determinants of reduced bone mineral density and increased bone turnover after kidney transplantation: cross-sectional study.
Kusec V; Smalcelj R; Cvijetić S; Rozman B; Skreb F
Croat Med J; 2000 Dec; 41(4):396-400. PubMed ID: 11063762
[TBL] [Abstract][Full Text] [Related]
11. Relationship between bone turnover and bone density at the proximal femur in stroke patients.
Paker N; Bugdayci D; Tekdos D; Dere C; Kaya B
J Stroke Cerebrovasc Dis; 2009; 18(2):139-43. PubMed ID: 19251190
[TBL] [Abstract][Full Text] [Related]
12. Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain.
Yano S; Sugimoto T; Tsukamoto T; Yamaguchi T; Hattori T; Sekita KI; Kaji H; Hattori S; Kobayashi A; Chihara K
Horm Metab Res; 2003 Apr; 35(4):259-64. PubMed ID: 12778370
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density and history of oral contraceptive use.
Fortney JA; Feldblum PJ; Talmage RV; Zhang J; Godwin SE
J Reprod Med; 1994 Feb; 39(2):105-9. PubMed ID: 8169923
[TBL] [Abstract][Full Text] [Related]
14. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
15. Prescribing of anti-osteoporotic therapies following the use of proton pump inhibitors in general practice.
McGowan B; Bennett K; Barry M
Pharmacoepidemiol Drug Saf; 2010 Jul; 19(7):763-9. PubMed ID: 20582909
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
Goffin E; Devogelaer JP; Lalaoui A; Depresseux G; De Naeyer P; Squifflet JP; Pirson Y; van Ypersele de Strihou C
Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
[TBL] [Abstract][Full Text] [Related]
17. Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years.
Haugeberg G; Ørstavik RE; Uhlig T; Falch JA; Halse JI; Kvien TK
Arthritis Rheum; 2002 Jul; 46(7):1720-8. PubMed ID: 12124854
[TBL] [Abstract][Full Text] [Related]
18. [Bone mineral density in patients with chronic renal failure at the start of haemodialysis therapy].
Valkovský I; Tvrdík J; Martínek A; Olšanská R; Dědochová J; Petejová N; Svagera Z; Pernicová M; Cermáková Z
Vnitr Lek; 2012 Nov; 58(11):817-24. PubMed ID: 23256826
[TBL] [Abstract][Full Text] [Related]
19. Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients.
Kirkpantur A; Altun B; Hazirolan T; Akata D; Arici M; Kirazli S; Turgan C
Artif Organs; 2009 Oct; 33(10):844-54. PubMed ID: 19681840
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors use and change in bone mineral density.
Arj A; Razavi Zade M; Yavari M; Akbari H; Zamani B; Asemi Z
Int J Rheum Dis; 2016 Sep; 19(9):864-8. PubMed ID: 27242025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
